Ryanair Holdings PLC
07 August 2002
RYANAIR SHAREHOLDERS APPROVE CONTRACT TO PURCHASE UP TO 150 BOEING AIRCRAFT
Ryanair shareholders today 7th August at an Extraordinary General Meeting (EGM)
approved the Boeing contract to purchase 100 firm 737-800 aircraft and up to 50
rolling options. The aircraft have a market value of $5bn and are to be
delivered between December 2002 and December 2008.
Commenting on the approval of the contract Ryanair's CEO Michael O'Leary said,
'We are pleased that the shareholders have demonstrated their continuing
commitment to grow the airline and approved the acquisition of 100 new Boeing
737-800 and up to 50 options. This is a further element of our long term growth
strategy which will enable us to offer even lower fares to more European
consumers over the next eight years'.
Ends. Wednesday, 7 August 2002
For further details contact:
Ryanair
Howard Millar
Tel: +353 1 8121212
Murray Consultants
Pauline McAlester
Tel: +353 1 6633332
www.Ryanair.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.